Symptomatic treatments of N-methyl-D-aspartate receptor encephalitis

Encephalitis. 2021 Jan;1(1):4-6. doi: 10.47936/encephalitis.2020.00045. Epub 2020 Dec 21.

Abstract

N-methyl-D-aspartate receptor (NMDAR) encephalitis presents with multiple symptoms including memory loss, seizure, psychosis, aphasia, altered mentality, dyskinesia, autonomic dysfunction, and central hypoventilation. While immunotherapy protocols are improving, morbidity and mortality in the disease largely depend on supportive care to control intractable symptoms. However, no prospective or controlled trials have been conducted on immunotherapy or supportive care principles in the disease. Thus, this study discusses and shares experience and ideas for symptomatic care of NMDAR encephalitis.

Keywords: Encephalitis; N-methyl-D-aspartate receptor; Symptomatic; Treatment.

Publication types

  • Review